I am pregnant and have eosinophilic esophagitis — Can I continue treatment? — Will my condition worsen?
When symptoms or doubts arise involving Eosinophilic EsophagitisDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "I'm pregnant and have eosinophilic esophagitis — Can I continue treatment? — Will my condition worsen?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.
Complementary Audiovisual Content: Click here to watch the full explanatory video on the official Brasil Sem Alergia YouTube channel..
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Pregnancy and Eosinophilic Esophagitis: What is the treatment and progression of the disease?
The discovery of pregnancy brings many questions, especially for women who live with chronic conditions such as eosinophilic esophagitis. Among the most frequent questions in the doctor's office are the fear that the disease will worsen, the concern about possible risks to the baby, and the uncertainty about the continuation of medications and dietary restrictions during this very special period.
The behavior of eosinophilic esophagitis during pregnancy presents some rather curious statistical data. It is observed that approximately seventy percent of pregnant women experience a significant improvement in symptoms throughout pregnancy, a condition that usually returns after childbirth. On the other hand, approximately thirty percent of patients may notice a worsening or persistence of symptoms. Although the exact mechanisms are not yet fully understood by science, it is believed that the profound hormonal and immunological changes typical of pregnancy play an important modulating role in this process.
A primary question is whether eosinophilic esophagitis can be transmitted to the baby. It is an inflammatory and immune-mediated condition of the esophagus, and not an infectious or directly transmissible genetic disease; therefore, it is not transmitted to the fetus.
Care with medication and nutritional treatment
Regarding the continuity of treatment, the fundamental guideline is that the patient should not interrupt follow-up or discontinue medication on her own. However, therapeutic management requires specific and individualized care:
- Proton pump inhibitors (PPIs): Medications such as omeprazole, lansoprazole, and pantoprazole, frequently used to reduce gastric acidity and control esophageal inflammation, have scientific evidence that requires caution, especially in the final months of pregnancy. The assessment of whether to continue or adjust these medications should be made exclusively by the attending physician.
- Topical corticosteroids (swallowed): The use of topical corticosteroids, such as swallowed fluticasone or budesonide, generally follows international protocols with risks considered minimal when indicated, but always requires rigorous medical supervision.
- Dietary restrictions: Elimination diets can continue to be followed to control the disease, but follow-up with a nutritionist is essential. This professional assistance ensures proper nutritional compensation, preventing deficiencies for both the mother and fetal development.
- Oral corticosteroids and immunobiologicals: The use of oral corticosteroids and monoclonal antibodies demands extreme care and strict restrictions during pregnancy and breastfeeding, due to the possibility of substances passing through the placenta or into breast milk. Any such course of action requires a thorough risk-benefit assessment conducted by a specialist.
Therefore, upon confirming pregnancy, a patient diagnosed with eosinophilic esophagitis should maintain an open and continuous dialogue with her allergist, obstetrician, and multidisciplinary team. This content is strictly educational and informative in nature and does not, under any circumstances, replace consultation, diagnosis, and individualized medical guidance offered by a qualified healthcare professional in the Brazil Without Allergies Project.
Developments in Evidence-Based Medicine: Pharmacokinetics and Safety of Corticosteroids
The consolidated guidelines of Evidence-Based Medicine (GINA, ARIA, and Allergy and Endocrinology consensus) establish a strict distinction between the... topical/inhaled corticosteroids — which act locally on the respiratory or cutaneous mucosa with minimal systemic bioavailability and constitute the safe basis for chronic anti-inflammatory control — and the Systemic corticosteroids (oral or injectable depot corticosteroids, such as the combination of betamethasone dipropionate and disodium phosphate)Injectable depot formulations maintain prolonged release for weeks, promoting suppression of the hypothalamic-pituitary-adrenal axis (risk of secondary adrenal insufficiency), hyperglycemia, hypertension, fluid retention, bone demineralization, subcapsular cataracts, and immunosuppression, and should not be used as maintenance therapy for rhinitis, asthma, or urticaria.
💎 Diamond Plan — Eating safely and without fear of adverse reactions starts with an accurate diagnosis. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis
Epithelial Barrier, Eosinophilic Inflammation, and Intestinal Permeability
Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.
Multidisciplinary Approach between Allergology and Gastroenterology
To achieve sustained clinical remission, a combined investigation is recommended, which should include endoscopic evaluation, allergy test thorough and specialized nutritional monitoring. The process is conducted through food allergy treatment Targeted treatment of the underlying cause reduces chronic mucosal inflammation and prevents long-term structural complications.
IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances
The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E
Choosing the ideal immunobiological agent requires rigorous phenotyping and endotyping by a specialist physician, evaluating blood biomarkers (peripheral eosinophil count, serum levels of total IgE and exhaled fraction of nitric oxide) and coexisting comorbidities, such as severe asthma, nasal polyposis, refractory chronic spontaneous urticaria, and moderate to severe atopic dermatitis. Subcutaneous applications follow a regular schedule under safe clinical supervision.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond PlanBrazil Without Allergies brings the same high standard of care from its clinics to your home, with telemedicine consultations and a more accessible path to immunotherapy. Eating safely and without fear of reactions starts with an accurate diagnosis.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Eosinophilic Esophagitis This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... allergy vaccine When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




